Researchers at UC San Diego simulated a 6.9 earthquake to see if this 10-story building would hold its integrity. Casey ...

A collaborative team from the School of Engineering and Applied Science and the Perelman School of Medicine have unraveled ...

John Mascarenhas, MD, discusses the rationale, mechanism, and design of the phase 1 INCA33989-101 and -102 trials investigating a CAL-R–targeted antibody for patients with essential thrombocythemia.

Mathieu Bennet: In B-cell cloning, single-cell isolation occurs at two crucial stages. First, during the initial screening ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & ...

The city of Dearborn is considering banning short-term rentals, like Airbnbs, inside residential parts of the city and is looking to add more zoning and code requirements.

The reconstituted C.D.C. panel will revisit the standard vaccination schedule. The former head of an anti-vaccine group is ...

Researchers have identified structural abnormalities at the myelin-axon interface in Alzheimer's that may hinder electrical ...

SEOUL, June 19 (Yonhap) -- Lotte Biologics Co., the biotech arm of Lotte Group, said Thursday it has signed a contract with ...

Infinity Bio, a biotechnology company pioneering technologies to map immune responses at scale, today announced the successful closing of an $8 million Series A financing round. The round was led by ...

Israel’s Teva Pharmaceutical Industries has announced that the final analysis of the pan-European PEARL Phase IV migraine ...